Cipla is currently priced at Rs 1443.70, with a 0.11% change today. The 3-day exponential moving average stands at Rs 1481.31. Cipla is currently trading at Rs 1441.10, showing a slight decline of ...

Cipla is currently trading at Rs 1511.15, showing a decline of 0.85% today, with a trading volume of 927,691 shares. Cipla's stock is currently valued at Rs 1511.9, reflecting a decrease of 0.8% today ...

Taipei: Taiwan-based Formosa Pharmaceuticals has announced an exclusive licensing agreement with Cipla Limited for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007 ...

Their work, published in Nature Communications, reveals a mechanism of interdependence of different forms of the cytoskeletal proteins actin and myosin, and their functions. The team also ...

Formosa and Cipla's agreement grants Cipla exclusive marketing rights for APP13007 in 11 countries, enhancing Cipla's ophthalmology portfolio. APP13007, approved by the FDA in March 2024, provides a ...

Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol propionate ophthalmic suspension 0.05% (APP13007) across 11 countries, including ...

Cipla, the Mumbai-based pharmaceutical company, has announced an exclusive licensing agreement with Taiwan's Formosa Pharmaceuticals to commercialise clobetasol propionate ophthalmic suspension. Under ...